 "Top headlines: Further GST relief for Covid drugs; over 2 mn jabbed today")
GST Council extends concessions on certain Covid drugs till Dec 31: FM
The GST Council, chaired by Finance Minister Nirmala Sitharaman, which met on Friday in Lucknow, took a slew of decisions, including extension of concessions to specified drugs used in Covid treatment till December 31, 2021. This was the first physical Goods and Services Tax (GST) meet since the Covid pandemic began.
GST Council granted exemption to two Covid drugs Zolgensma and Viltepso. Read more
India administers 20 mn vaccine doses, sets new record on PM's birthday
India set a record on Friday by administering over 20 million COVID-19 vaccine doses, in a major push to the inoculation drive on the occasion of Prime Minister Narendra Modi's birthday.
The cumulative doses administered in the country reached 2,00,41,136 at 5.10 pm, according to data on the Co-WIN portal. Read more
World Bank to discontinue 'Doing Business' report after China-linked probe
The World Bank Group has decided to discontinue publication of its Doing Business report on country investment climates following allegations of irregularities.
The decision was taken after a probe of data irregularities allegedly due to pressure by some top bank officials to boost China's ranking in 2017 came to light. Read more
Telecom relief package credit positive for Airtel, Jio, says Moody's
The telecom sector reforms package announced by the government will sustain telcos' businesses, is credit positive for operators, including Airtel and Jio, and provides support for 3+1 players structure, Moody's Investors Service said on Friday.
The views come against the backdrop of a blockbuster relief package announced earlier this week for the telecom sector that includes a four-year break for companies from paying statutory dues, permission to share scarce airwaves, change in the definition of revenue on which levies are paid, and 100 per cent foreign investment through the automatic route. Read more
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%